July 2008 Oncology News International

Publication
Article

Cover Story

Dr. Larry Norton & the Case of the Recurring Mass

Novel Agents May Overcome Resistance to Trastuzumab

DEPARTMENTS

Focus on Breast Cancer

Lapatinib Plus Trastuzumab Extends Progression-Free Survival in Women With HER2-Positive Metastatic Breast Cancer

International News

Bevacizumab Improves PFS in Advanced Breast Cancer

Focus on Lung Cancer

RNA Analysis Can Predict Lung Cancer Among Smokers

Focus on Prostate Cancer

Custirsen, an Antisense Oligonucleotide, May Enhance Docetaxel Efficacy in Hormone-Refractory Prostate Cancer

Vantage Point: Impressive' Pain results; Tolerability Questioned

Focus on Colon Cancer

KRAS Status Predicts Benefit for Cetuximab in Met Colon Ca

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content